MindWalk Holdings HYFT
NASDAQ HYFT
$1.32 -0.01 (-0.75%)
As of: Sep 4, 2026 · 11:47 AM EDT

MindWalk Holdings (HYFT) Consolidated Net Income (2020 - 2026)

MindWalk Holdings (HYFT) posted quarterly Consolidated Net Income of $930.12 for Q2 2026, down 99.9% year-over-year from $895979.1 in Q2 2025, and up 29.8% quarter-over-quarter from $716.55 in Q4 2025.

Analysis

MindWalk Holdings (HYFT) Consolidated Net Income (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has reported Consolidated Net Income for 7 consecutive years, with $930.12 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Consolidated Net Income fell 99.9% year-over-year to $930.12; the TTM figure through Apr 2026 stood at $821.7 million (up 421.75% YoY), while the FY2026 annual figure was $841120.4, down 59.78% from the prior year.
  • Consolidated Net Income grew to $930.12 in Q2 2026 per HYFT's latest filing, from $716.55 in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $3.1 billion in Q3 2023 and bottomed at -$32.9 million in Q2 2023.
  • Historically, Consolidated Net Income has averaged $313.9 million across 5 years, with a median of $727895.0 in 2024.
  • Annual changes were most pronounced in 2022 — Consolidated Net Income plunged 328.73% — and 2023, when it jumped 1025793.57%.
  • MindWalk Holdings' Consolidated Net Income stood at $3.9 million in 2022, then jumped by 32982.56% to $1.3 billion in 2023, then slumped by 99.94% to $727895.0 in 2024, then tumbled by 99.9% to $716.55 in 2025, then climbed by 29.8% to $930.12 in 2026.
  • Business Quant data shows HYFT's Consolidated Net Income at $930.12 in Q2 2026, $716.55 in Q4 2025, and $821.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 140.22 Bn 132.37 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.70 Bn 58.52 Bn 1.37 Bn 601.00 Mn
4 Moderna 57.56 Bn 52.42 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 40.16 Bn 35.06 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.63 Bn 32.32 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.63 Bn 27.79 Bn - 81.49 Mn
9 Insmed 27.73 Bn 26.57 Bn 358.27 Mn -13.27 Mn
10 MindWalk Holdings 61.22 Mn 52.95 Mn 1.82 Mn -2.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -2.50 Mn
Jan 31, 2026 -2.66 Mn
Oct 31, 2025 -1.97 Mn
Jul 31, 2025 1.01 Mn
Apr 30, 2025 -13.25 Mn
Jan 31, 2025 -19.33 Mn
Oct 31, 2024 -2.78 Mn
Jul 31, 2024 75,222.13
Apr 30, 2024 -17.56 Mn
Jan 31, 2024 -3.05 Mn
Oct 31, 2023 -2.21 Bn
Jul 31, 2023 -3.03 Bn
Apr 30, 2023 -5.82 Mn
Jan 31, 2023 -3.32 Mn
Oct 31, 2022 -5.53 Mn
Jul 31, 2022 -7.52 Mn
Apr 30, 2022 -4.19 Mn
Jan 31, 2022 -3.57 Mn
Oct 31, 2021 -3.88 Mn
Jul 31, 2021 -2.97 Mn